Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale COO and Secretary sold 1,468 shares at an average $74.80 ($109,809)
  2. 4 Open-market sale CFO and Treasurer sold 1,448 shares at an average $74.68 ($108,135)
  3. 4 Open-market sale Chief Medical Officer sold 1,470 shares at an average $74.68 ($109,785)
  4. 4 Open-market sale President and CEO sold 5,112 shares at an average $73.79 ($377,211)
  5. 4 Open-market sale COO and Secretary sold 10,000 shares at an average $67.84 ($678,361)
  6. 4 Open-market sale President and CEO sold 18,334 shares at an average $68.44 ($1,254,819)
  7. 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $71.45 ($3,572,556)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale COO and Secretary sold 70,000 shares at an average $74.95 ($5,246,408)
  13. 4 Open-market sale President and CEO sold 88,334 shares at an average $74.96 ($6,621,782)
  14. 4 Open-market sale Director sold 30,000 shares at an average $90.05 ($2,701,582)
  15. 4 Other disposition 10% owner disposed of 383,411 shares (other)
  16. 4 Open-market sale 10% owner sold 64,624 shares at an average $80.14 ($5,179,285)
  17. 4/A Open-market sale Chief Medical Officer sold 17,500 shares at an average $19.44 ($340,168)
  18. 4/A Open-market sale Chief Medical Officer sold 17,500 shares at an average $18.45 ($322,834)
  19. 4/A Open-market sale Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)
  20. 4/A Shares withheld for taxes COO and Secretary gave up 1,954 shares (to pay taxes)

Page 14 of 22 · 436 filings